ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Jianyu Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0195-4100; OpenAlex author ID A5001655498. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yongwei Sun · 2 shared papers, 2015–2024 · strength 0.23
- Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w ↗
- Paper High expression of WISP-1 correlates with poor prognosis in pancreatic ductal adenocarcinoma. PMID 26550461 ↗
Dejun Liu · 2 shared papers, 2015–2024 · strength 0.23
- Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w ↗
- Paper High expression of WISP-1 correlates with poor prognosis in pancreatic ductal adenocarcinoma. PMID 26550461 ↗
Minwei Yang · 2 shared papers, 2015–2024 · strength 0.23
- Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w ↗
- Paper High expression of WISP-1 correlates with poor prognosis in pancreatic ductal adenocarcinoma. PMID 26550461 ↗
Rong Hua · 2 shared papers, 2015–2024 · strength 0.23
- Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w ↗
- Paper High expression of WISP-1 correlates with poor prognosis in pancreatic ductal adenocarcinoma. PMID 26550461 ↗
Yan‐Miao Huo · 2 shared papers, 2015–2024 · strength 0.23
- Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w ↗
- Paper High expression of WISP-1 correlates with poor prognosis in pancreatic ductal adenocarcinoma. PMID 26550461 ↗
Zong‐Hao Duan · 1 shared paper, 2024 · strength 0.18
- Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w ↗
Xueliang Fu · 1 shared paper, 2024 · strength 0.18
- Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w ↗
Qin-Yuan Jia · 1 shared paper, 2024 · strength 0.18
- Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w ↗
Jia-Hao Zheng · 1 shared paper, 2024 · strength 0.18
- Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w ↗
Yifan Yin · 1 shared paper, 2024 · strength 0.18
- Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w ↗
Hong‐Fei Yao · 1 shared paper, 2024 · strength 0.18
- Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w ↗
Wei Liu · 1 shared paper, 2024 · strength 0.18
- Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.